Description: The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (?index?). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
Exchange: BATS
Country: US : United States of America
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 84.55 | 0.00 | 84.55 |
| Stock non-US | 15.45 | 0.00 | 15.45 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 84.83 | 99.78 |
| Basic Materials | 10.99 | 0.00 |
| Consumer Defensive | 3.52 | 0.03 |
| Consumer Cyclicals | 0.66 | 0.00 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 85.15 | 90.74 |
| Europe Developed | 10.80 | 6.15 |
| United Kingdom | 2.11 | 2.07 |
| Japan | 1.33 | 0.50 |
| Australasia | 0.61 | 0.08 |
| Asia Emerging | 0.00 | 0.34 |
| Asia Developed | 0.00 | 0.03 |
| Africa/Middle East | 0.00 | 0.10 |